Ukraine ranks 26th in the world in terms of mortality, according to the UN for 2010-2015. As of today, the main causes of death in the country include circulatory diseases, neoplasms, suicide, road accidents, and post-surgery complications. Farmak annually produces over 20 new medical products aimed at the treatment and prevention of various diseases belonging to the risk group for Ukrainians. These are complex generic medicinal products with proven efficiency, which have been developed and manufactured by our employees on the most up-to-date European pharmaceutical equipment. These medicinal products are supplied from the same GMP-certified line to both Ukrainian and European pharmacies, which once again proves the high quality of medicinal products we produce. It is very important for us, as a pharmaceutical company, that the medicine in the country has a high level and meets modern requirements and the needs of society.
Maintaining a high level of knowledge and expertise of Ukrainian doctors in accordance with the global trends and standards is our main task, which has been systematically implemented by Farmak within the Level program since the beginning of 2010.
Within the framework of reimbursement programs, the government has chosen directions that are important for the country. They include cardiovascular diseases, diabetes of the level ll, and bronchial asthma. As a result, Ukrainians are provided with the relevant necessary medicines. We, in turn, strive to ensure that doctors working in these and other areas are able to provide qualified assistance using the knowledge and experience gained during training courses within our program. It is impossible to be on the side of progress in today’s world of advanced technology. Therefore, we provide the opportunity to practice on modern equipment to future doctors and pharmacists from seven universities of the country. We do not stop helping them to improve their knowledge and skills starting from their student days. In 2018, Farmak trained healthcare professionals in the field of obstetrics and gynecology, anesthesiology, surgery, neurology, diabetes, and traumatology. New directions launched in 2018 include gastroenterological training, school of nebulizer therapy for pediatricians and training of ambulance paramedics.
